Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers
- PMID: 24331841
- DOI: 10.1016/j.humpath.2013.09.004
Prognostic implications of tumor-infiltrating FoxP3+ regulatory T cells and CD8+ cytotoxic T cells in microsatellite-unstable gastric cancers
Abstract
Microsatellite instability (MSI)-high gastric cancers (GC) have better prognosis and higher levels of tumor-infiltrating lymphocytes (TIL) compared with MSI-low or MSI-stable GCs. TILs are part of the adaptive immune response against tumor growth and are associated with improved prognosis in GCs. The aim of this study was to investigate the prognostic significance of CD8+ and FoxP3+ TILs in MSI-high GCs and their relationships with various clinicopathologic characteristics. Intratumoral intraepithelial CD8+ and FoxP3+ TILs were assessed in 99 cases of MSI-high GCs using a computerized image analysis system. TILs were grouped into low- and high-density groups and were analyzed for their relationships with clinicopathologic parameters. A low density was closely associated with a higher TNM stage (P = .040) and invasion depth (P = .044) and more frequent lymphatic and vascular invasion (P = .033 and .015, respectively). GCs with high-density CD8+ or FoxP3+ TILs showed significantly higher overall survival rates than those of GCs with low-density CD8+ or FoxP3+ TILs (P = .017 and .013, respectively, Kaplan-Meier test). In multivariate survival analysis, a high density of FoxP3+ TILs was significantly associated with improved overall survival (P = .027; hazard ratio, 0.269), and the combinatorial status of CD8+ and FoxP3+ TIL density was an independent prognostic factor (P = .003). Our results demonstrate that higher densities of both intratumoral CD8+ and FoxP3+ TILs are associated with good prognosis, suggesting a synergistic activity of these 2 subsets that can be used as an independent prognostic factor in MSI-high GCs.
Keywords: Gastric cancer; Microsatellite instability; Tumor infiltrating lymphocytes.
© 2014.
Similar articles
-
Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response.Oncologist. 2019 Sep;24(9):e835-e844. doi: 10.1634/theoncologist.2018-0273. Epub 2019 Mar 20. Oncologist. 2019. PMID: 30894409 Free PMC article.
-
Prognostic significance of tumor-infiltrating CD8+ and FOXP3+ lymphocytes in residual tumors and alterations in these parameters after neoadjuvant chemotherapy in triple-negative breast cancer: a retrospective multicenter study.Breast Cancer Res. 2015 Sep 4;17(1):124. doi: 10.1186/s13058-015-0632-x. Breast Cancer Res. 2015. PMID: 26341640 Free PMC article.
-
Intratumour T cells, their activation status and survival in gastric carcinomas characterised for microsatellite instability and Epstein-Barr virus infection.Virchows Arch. 2006 Mar;448(3):344-53. doi: 10.1007/s00428-005-0066-4. Epub 2005 Oct 27. Virchows Arch. 2006. PMID: 16261379
-
The prognostic value of tumor-infiltrating lymphocytes in triple-negative breast cancer: a meta-analysis.Breast Cancer Res Treat. 2014 Dec;148(3):467-76. doi: 10.1007/s10549-014-3185-2. Epub 2014 Nov 1. Breast Cancer Res Treat. 2014. PMID: 25361613 Review.
-
Association between density of tumor-infiltrating lymphocytes and prognoses of patients with gastric cancer.Medicine (Baltimore). 2018 Jul;97(27):e11387. doi: 10.1097/MD.0000000000011387. Medicine (Baltimore). 2018. PMID: 29979429 Free PMC article. Review.
Cited by
-
Immunoscore is a strong predictor of survival in the prognosis of stage II/III gastric cancer patients following 5-FU-based adjuvant chemotherapy.Cancer Immunol Immunother. 2021 Feb;70(2):431-441. doi: 10.1007/s00262-020-02694-6. Epub 2020 Aug 12. Cancer Immunol Immunother. 2021. PMID: 32785776 Free PMC article.
-
From Tumor Immunology to Immunotherapy in Gastric and Esophageal Cancer.Int J Mol Sci. 2018 Dec 20;20(1):13. doi: 10.3390/ijms20010013. Int J Mol Sci. 2018. PMID: 30577521 Free PMC article. Review.
-
An immunosuppressive scoring system to predict recurrence and assist in decision regarding postoperative adjuvant treatment in gastric cancer.Am J Cancer Res. 2022 May 15;12(5):2050-2067. eCollection 2022. Am J Cancer Res. 2022. PMID: 35693074 Free PMC article.
-
Prognostic perspectives of PD-L1 combined with tumor-infiltrating lymphocytes, Epstein-Barr virus, and microsatellite instability in gastric carcinomas.Diagn Pathol. 2020 Jun 4;15(1):69. doi: 10.1186/s13000-020-00979-z. Diagn Pathol. 2020. PMID: 32498695 Free PMC article.
-
Loss of ARID1A Expression in Gastric Cancer: Correlation with Mismatch Repair Deficiency and Clinicopathologic Features.J Gastric Cancer. 2015 Sep;15(3):201-8. doi: 10.5230/jgc.2015.15.3.201. Epub 2015 Sep 30. J Gastric Cancer. 2015. PMID: 26468418 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous